WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (339)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Otto, D.
Right arrow Articles by Unsicker, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otto, D.
Right arrow Articles by Unsicker, K.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 10, 1912-1921, Copyright © 1990 by Society for Neuroscience


ARTICLE

Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice

D Otto and K Unsicker
Philipps-University, Department of Anatomy and Cell Biology, Marburg, Federal Republic of Germany.

The specific mechanisms underlying the restorative effects of adrenal chromaffin grafts in experimental parkinsonism are still obscure. Recent findings indicated an involvement of graft-induced trophic interactions in the course of recovery-related events. Evidence that basic fibroblast growth factor (bFGF), a potent trophic protein for neurons, (1) is present in chromaffin cells (Blottner et al., 1989) and (2) exerts trophic activities on embryonic mesencephalic neurons in vitro (Ferrari et al., 1989) provided the rationale for administering bFGF in gel foam implants unilaterally to the striatum of 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP) lesioned mice. Simultaneous bFGF/MPTP treatment diminished bilaterally the reduction of striatal dopamine (DA) levels observed in cytochrome c/MPTP-treated mice and led to an ipsilateral reappearance of tyrosine hydroxylase (TH)-like immunoreactive fibers, most notably adjacent to the implant, 2 weeks after the surgery. Determinations of TH activities and TH immunoblotting demonstrated that bFGF almost fully reversed the loss of TH activity on either side but restored TH protein more on the ipsilateral than on the contralateral side. Furthermore, differences in dihydroxyphenylacetic acid levels, which were about twice as high on the contralateral side yet still reduced with respect to untreated mice, supported our assumption that the molar TH activity was increased on the untreated side, possibly due to an intrinsic compensatory up- regulation. Delayed administration of bFGF starting 8 d after the MPTP treatment was equally effective with regard to morphological parameters. Our results suggest that bFGF partially prevents the deleterious chemical and morphological consequences of an MPTP-mediated nigrostriatal lesion. Thus, bFGF mimics at least the morphological effects of chromaffin cell grafts to the MPTP-lesioned brain.


This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. Murase and R. D. McKay
A specific survival response in dopamine neurons at most risk in Parkinson's disease.
J. Neurosci., September 20, 2006; 26(38): 9750 - 9760.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S.-L. Hsuan, H. M. Klintworth, and Z. Xia
Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways.
J. Neurosci., April 26, 2006; 26(17): 4481 - 4491.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
D. Reimers, A. S. Herranz, J. J. Diaz-Gil, M. V. T. Lobo, C. L. Paino, R. Alonso, M. J. Asensio, R. Gonzalo-Gobernado, and E. Bazan
Intrastriatal Infusion of Liver Growth Factor Stimulates Dopamine Terminal Sprouting and Partially Restores Motor Function in 6-Hydroxydopamine-lesioned Rats
J. Histochem. Cytochem., April 1, 2006; 54(4): 457 - 465.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
W. -L. Kuan and R. A. Barker
New Therapeutic Approaches to Parkinson's Disease Including Neural Transplants
Neurorehabil Neural Repair, September 1, 2005; 19(3): 155 - 181.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
H. Yamada, E. Yamada, A. Ando, N. Esumi, N. Bora, J. Saikia, C.-H. Sung, D. J. Zack, and P. A. Campochiaro
Fibroblast Growth Factor-2 Decreases Hyperoxia-Induced Photoreceptor Cell Death in Mice
Am. J. Pathol., September 1, 2001; 159(3): 1113 - 1120.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Ho and M. Blum
Induction of Interleukin-1 Associated with Compensatory Dopaminergic Sprouting in the Denervated Striatum of Young Mice: Model of Aging and Neurodegenerative Disease
J. Neurosci., August 1, 1998; 18(15): 5614 - 5629.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Fornai, M. G. Alessandrì, M. T. Torracca, L. Bassi, and G. U. Corsini
Effects of Noradrenergic Lesions on MPTP/MPP+ Kinetics and MPTP-Induced Nigrostriatal Dopamine Depletions
J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 100 - 107.
[Abstract]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-